GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
7SP9 | M1H2Q1 | Chlorella virus Hyaluronan Synthase in the GlcNAc-primed channel-closed state | |
7SP9 | 7SP9 | Chlorella virus Hyaluronan Synthase in the GlcNAc-primed channel-closed state | |
7SP5 | A8N031 | Crystal Structure of a Eukaryotic Phosphate Transporter | |
7SOF | P0DTC2 | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement | |
7SOF | 7SOF | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement | |
7SOE | P0DTC2 | SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement | |
7SOE | 7SOE | SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement | |
7SOD | P0DTC2 | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement | |
7SOD | 7SOD | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement | |
7SOC | P0DTC2 | SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement | |
7SOC | 7SOC | SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement | |
7SOB | P0DTC2 | SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement | |
7SOB | 7SOB | SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement | |
7SOA | P0DTC2 | SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement | |
7SOA | 7SOA | SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement | |
7SO9 | P0DTC2 | SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement | |
7SO9 | 7SO9 | SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement | |
7SNO | B5CYA4 | Structure of Bacple_01701(H214N), a 6-O-galactose porphyran sulfatase | |
7SNI | P11413 | Structure of G6PD-D200N tetramer bound to NADP+ and G6P | |
7SN3 | P0DTC2 | Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region) | |
7SN3 | 7SN3 | Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region) | |
7SN2 | P0DTC2 | Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab | |
7SN2 | 7SN2 | Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab | |
7SN0 | Q9BYF1 | Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2 | |
7SN0 | A0A7U0MIF7 | Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2 | |
7SMT | P02710 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with d-tubocurarine and carbachol | |
7SMT | P02718 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with d-tubocurarine and carbachol | |
7SMT | P02712 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with d-tubocurarine and carbachol | |
7SMT | P02714 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with d-tubocurarine and carbachol | |
7SMS | P02710 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with d-tubocurarine | |
7SMS | P02718 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with d-tubocurarine | |
7SMS | P02712 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with d-tubocurarine | |
7SMS | P02714 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with d-tubocurarine | |
7SMR | P02710 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with carbachol, desensitized state | |
7SMR | P02718 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with carbachol, desensitized state | |
7SMR | P02712 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with carbachol, desensitized state | |
7SMR | P02714 | Cryo-EM structure of Torpedo acetylcholine receptor in complex with carbachol, desensitized state | |
7SMQ | P02710 | Cryo-EM structure of Torpedo acetylcholine receptor in apo form with added cholesterol | |
7SMQ | P02718 | Cryo-EM structure of Torpedo acetylcholine receptor in apo form with added cholesterol | |
7SMQ | P02712 | Cryo-EM structure of Torpedo acetylcholine receptor in apo form with added cholesterol | |
7SMQ | P02714 | Cryo-EM structure of Torpedo acetylcholine receptor in apo form with added cholesterol | |
7SMM | P02710 | Cryo-EM structure of Torpedo acetylcholine receptor in apo form | |
7SMM | P02718 | Cryo-EM structure of Torpedo acetylcholine receptor in apo form | |
7SMM | P02712 | Cryo-EM structure of Torpedo acetylcholine receptor in apo form | |
7SMM | P02714 | Cryo-EM structure of Torpedo acetylcholine receptor in apo form | |
7SLY | O95497 | Vanin-1 complexed with Compound 27 | |
7SLX | O95497 | Vanin-1 complexed with Compound 11 | |
7SLV | O95497 | Vanin-1 complexed with Compound 3 | |
7SKA | Q6TAN8 | Sub-tomogram averaged structure of HIV-1 Envelope protein in native membrane | |
7SJQ | Q9NZQ7 | Ex silico engineering of cystine-dense peptides yielding a potent bispecific T-cell engager |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024